Health and Healthcare

Merck : MRK

All Merck Articles

1079 Articles

Jon C. Ogg | Nov 19, 2013 at 11:50 AM EST

The $1 Trillion Drug Market Offers Great but Selective Growth in the Next Five Years

ThinkstockThe market for pharmaceuticals and biotech drugs just keeps growing. The so-called patent cliff may be affecting Big Pharma companies…

Jon C. Ogg | Nov 18, 2013 at 2:16 PM EST

Merck Scores in Investigational Melanoma Study Results

ThinkstockSkin cancer treatments remain elusive. While some drugs are on the market for advanced-stage treatment, the most common and longest…

Lee Jackson | Nov 13, 2013 at 8:25 AM EST

UBS Top Stocks to Buy for 2014: GE, GM, Citigroup and Six More

While the past two years were all about getting the house back in order, the UBS equity strategy team thinks…

Jon C. Ogg | Nov 12, 2013 at 9:00 AM EST

Short Sellers Made Big Changes in High-Yield Dividend Stocks

We have now seen the short interest reports from the October 31 settlement date and have compared them to the…

Douglas A. McIntyre | Nov 9, 2013 at 8:30 AM EST

The Six Companies Cutting the Most Jobs in October

ThinkstockThe unemployment situation in the United States looked relatively good through the first half of the year. The jobless rate…

Douglas A. McIntyre | Nov 8, 2013 at 6:52 AM EST

Can U.S. Add Two Million Jobs This Year?

ThinkstockOctober’s jobs report showed a gain of 204,000 people to nonfarm payrolls. That is a pace of 1.5 million job additions…

Jon C. Ogg | Oct 30, 2013 at 8:05 AM EDT

Top Analyst Upgrades and Downgrades: BP, 3D Systems, Nike, SanDisk and More

Jon OggInvestors are having to deal with seeing stocks hit new highs almost daily now. With a temporary deal in…

Jon C. Ogg | Oct 28, 2013 at 1:19 PM EDT

Merck Sets Low Earnings Bar for Pfizer

The drug patent cliff for Big Pharma is coming with some continued consequences, and two drug giants with earnings this…

Paul Ausick | Oct 28, 2013 at 7:50 AM EDT

Merck Continues to Face Revenue Challenges

ThinkstockDrug giant Merck & Co. Inc. (NYSE: MRK) reported third-quarter 2013 results before markets opened Monday morning. The company posted…

Douglas A. McIntyre | Oct 28, 2013 at 6:46 AM EDT

A New Rise in Global Mergers/Buyouts

courtesy of Verizon WirelessMergers and acquisitions (M&A) sometimes can be an excellent measure of the economy’s financial health. However, since…

Jon C. Ogg | Oct 27, 2013 at 8:38 AM EDT

The 10 Most Important Earnings in the Week Ahead

Jon OggEarnings season is in full swing and this coming week will bring many key earnings reports. This will also…

Jon C. Ogg | Oct 25, 2013 at 8:50 AM EDT

Short Sellers Abandoning Bets Against High-Yield Defensive Dividend Stocks

We have seen the short interest reports for the October 15 settlement date. It turns out that short sellers have…

Lee Jackson | Oct 16, 2013 at 8:50 AM EDT

Merrill Lynch Technical Titans List Scans for Best Stocks to Buy

Courtesy Boeing Co.The Merrill Lynch Technical Titans List was formerly known as the Most Attractive Buy List and was introduced…

Trey Thoelcke | Oct 14, 2013 at 8:15 AM EDT

Jefferies Top Biotech Stocks to Buy

ThinkstockThe world of biotechnology investing is a constantly evolving and changing one. While disease for the most part does not…

Jon C. Ogg | Oct 11, 2013 at 8:10 AM EDT

Top Analyst Upgrades and Downgrades: Corning, Intel, Merck, Micron and More

Jon OggA new earnings season has started, and stocks and bonds are dealing with a likely patch for the government…

1 … 50 51 52 53 54 … 72

Merck : MRK

All Merck Articles

The $1 Trillion Drug Market Offers Great but Selective Growth in the Next Five Years

Merck Scores in Investigational Melanoma Study Results

UBS Top Stocks to Buy for 2014: GE, GM, Citigroup and Six More

Short Sellers Made Big Changes in High-Yield Dividend Stocks

The Six Companies Cutting the Most Jobs in October

Can U.S. Add Two Million Jobs This Year?

Top Analyst Upgrades and Downgrades: BP, 3D Systems, Nike, SanDisk and More

Merck Sets Low Earnings Bar for Pfizer

Merck Continues to Face Revenue Challenges

A New Rise in Global Mergers/Buyouts

The 10 Most Important Earnings in the Week Ahead

Short Sellers Abandoning Bets Against High-Yield Defensive Dividend Stocks

Merrill Lynch Technical Titans List Scans for Best Stocks to Buy

Jefferies Top Biotech Stocks to Buy

Top Analyst Upgrades and Downgrades: Corning, Intel, Merck, Micron and More

Prediction: Pfizer Stock Will Double on This Date

SMH ETF Investors: Watch Hyperscaler Capex Guidance at July Earnings Calls

The Average American Has Worked for 6 Employers and 23% Still Have Multiple Old Retirement Accounts, Fidelity’s 2026 Study Finds

The Average American Has Worked for 6 Employers and 23% Still Have Multiple Old Retirement Accounts, Fidelity's 2026 Study Finds

Fidelity's 2026 Study: 76% of Boomers Are Counting on Social Security While Younger Generations Lean on Workplace Plans

Prediction: Pfizer Stock Will Double on This Date

SMH ETF Investors: Watch Hyperscaler Capex Guidance at July Earnings Calls

Merck : MRK

All Merck Articles

The $1 Trillion Drug Market Offers Great but Selective Growth in the Next Five Years

Merck Scores in Investigational Melanoma Study Results

UBS Top Stocks to Buy for 2014: GE, GM, Citigroup and Six More

Short Sellers Made Big Changes in High-Yield Dividend Stocks

The Six Companies Cutting the Most Jobs in October

Can U.S. Add Two Million Jobs This Year?

Top Analyst Upgrades and Downgrades: BP, 3D Systems, Nike, SanDisk and More

Merck Sets Low Earnings Bar for Pfizer

Merck Continues to Face Revenue Challenges

A New Rise in Global Mergers/Buyouts

The 10 Most Important Earnings in the Week Ahead

Short Sellers Abandoning Bets Against High-Yield Defensive Dividend Stocks

Merrill Lynch Technical Titans List Scans for Best Stocks to Buy

Jefferies Top Biotech Stocks to Buy

Top Analyst Upgrades and Downgrades: Corning, Intel, Merck, Micron and More

Prediction: Pfizer Stock Will Double on This Date

SMH ETF Investors: Watch Hyperscaler Capex Guidance at July Earnings Calls

The Average American Has Worked for 6 Employers and 23% Still Have Multiple Old Retirement Accounts, Fidelity’s 2026 Study Finds

Featured Reads

The Average American Has Worked for 6 Employers and 23% Still Have Multiple Old Retirement Accounts, Fidelity's 2026 Study Finds

Fidelity's 2026 Study: 76% of Boomers Are Counting on Social Security While Younger Generations Lean on Workplace Plans